Fierce Pharma
FDA's Makary shares policy requests with Congress
One year into his tumultuous tenure as the FDA’s commissioner, Marty Makary, M.D., has laid out ambitious internal goals and ...
BioPharma Dive
FDA, after turbulent year, leaves drugmakers guessing on its direction
Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
Pharmaceutical Technology on MSN
FDA seeks permanent future for rare pediatric priority review vouchers
The rare disease framework has had a turbulent past few years, with the FDA looking to create regulatory stability.
FDA’s Makary touts ‘healing’ following DOGE cuts
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story FDA commissioner credits himself with ...